HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency.

Abstract
Previous reports on pernicious anemia treatment suggested that high folic acid intake adversely influences the natural history of vitamin B-12 deficiency, which affects many elderly individuals. However, experimental investigation of this hypothesis is unethical, and the few existing observational data are inconclusive. With the use of data from the 1999-2002 National Health and Nutrition Examination Survey (NHANES), we evaluated the interaction between high serum folate and low vitamin B-12 status [ie, plasma vitamin B-12 < 148 pmol/L or methylmalonic acid (MMA) > 210 nmol/L] with respect to anemia and cognitive impairment. With subjects having both plasma folate < or = 59 nmol/L and normal vitamin B-12 status as the referent category, odds ratios for the prevalence of anemia compared with normal hemoglobin concentration and impaired compared with unimpaired cognitive function were 2.1 (95% CI: 1.1, 3.7) and 1.7 (95% CI: 1.01, 2.9), respectively, for those with low vitamin B-12 status but normal serum folate and 4.9 (95% CI: 2.3, 10.6) and 5.0 (95% CI: 2.7, 9.5), respectively, for those with low vitamin B-12 status and plasma folate >59 nmol/L. Among subjects with low vitamin B-12 status, mean circulating vitamin B-12 was 228 pmol/L for the normal-folate subgroup and 354 pmol/L for the high-folate subgroup. We subsequently showed increases in circulating homocysteine and MMA concentrations with increasing serum folate among NHANES participants with serum vitamin B-12 < 148 pmol/L, whereas the opposite trends occurred among subjects with serum vitamin B-12 > or = 148 pmol/L. These interactions, which were not seen in NHANES III before fortification, imply that, in vitamin B-12 deficiency, high folate status is associated with impaired activity of the 2 vitamin B-12-dependent enzymes, methionine synthase and MMA-coenzyme A mutase.
AuthorsJacob Selhub, Martha Savaria Morris, Paul F Jacques, Irwin H Rosenberg
JournalThe American journal of clinical nutrition (Am J Clin Nutr) Vol. 89 Issue 2 Pg. 702S-6S (Feb 2009) ISSN: 1938-3207 [Electronic] United States
PMID19141696 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Homocysteine
  • Methylmalonic Acid
  • Folic Acid
  • 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
  • Methylmalonyl-CoA Mutase
  • Vitamin B 12
Topics
  • 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (metabolism)
  • Aging (blood)
  • Anemia, Pernicious (blood, diagnosis, epidemiology)
  • Cognition Disorders (blood, diagnosis, epidemiology)
  • Drug Interactions
  • Female
  • Folic Acid (administration & dosage, blood)
  • Homocysteine (blood)
  • Humans
  • Male
  • Methylmalonic Acid (blood)
  • Methylmalonyl-CoA Mutase (metabolism)
  • Middle Aged
  • Nutrition Surveys
  • Nutritional Status
  • Odds Ratio
  • Prevalence
  • Vitamin B 12 (administration & dosage, blood)
  • Vitamin B 12 Deficiency (blood, diagnosis, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: